首页|期刊导航|诊断学理论与实践|非小细胞肺癌的气道播散临床意义及研究进展

非小细胞肺癌的气道播散临床意义及研究进展OA

Clinical significance and research progress of spread through air spaces(STAS)in non-small cell lung cancer

中文摘要英文摘要

气道播散(spread through air spaces,STAS)是指肿瘤细胞出现在主瘤边缘之外的肺实质气腔内,是一种新发现的肺癌传播方式.自2015年被世界卫生组织正式定义以来,已彻底重塑了非小细胞肺癌(non-small cell lung cancer,NSCLC)的风险分层与治疗体系.随着JCOG0802(Japan Clinical Oncology Group,日本临床肿瘤学组)/WJOG4607L(West Japan Oncology Group,西日本肿瘤学组)大型临床研究数据的公布,STAS已从单纯的病理学特征,演变为早期NSCLC无复发生存期和总生存期的独立危险因素,是决定外科手术方式(肺叶切除或亚肺叶切除)和术后辅助治疗决策的核心生物标志物.本文将系统性介绍STAS的定义、诊断及术前多模态影像预测模型,阐明基于STAS状态的手术切除范围选择以及辅助治疗的最新循证医学证据,旨在为临床医师规范化诊治提供实践指导.

Spread through air spaces(STAS),defined as the presence of tumor cells within the air spaces of the lung parenchyma beyond the edge of the main tumor,represents a novel pattern of invasion in lung cancer.Since its formal defi-nition by the World Health Organization in 2015,STAS has fundamentally reshaped the risk stratification and treatment paradigms for non-small cell lung cancer(NSCLC).With the publication of data from the large-scale JCOG0802/WJOG4607L clinical trials conducted by the Japan Clinical Oncology Group and the West Japan Oncology Group,STAS has evolved from a mere pathological feature into an independent risk factor affecting recurrence-free survival(RFS)and overall survival(OS)in early-stage NSCLC,emerging as a pivotal biomarker for determining the surgical approach(lobec-tomy or sublobar resection)and postoperative adjuvant therapy decisions.This review systematically outlines the definition,diagnosis,and preoperative multimodal imaging prediction models of STAS.Furthermore,it elucidates the selection of sur-gical resection extent based on STAS status and presents the latest evidence-based data regarding adjuvant therapy,aiming to provide practical guidance for clinicians in standardizing diagnosis and treatment.

钟华;黄莉棠;杜华薇

上海交通大学医学院附属胸科医院呼吸与危重症医学科,上海 200030上海交通大学医学院附属胸科医院呼吸与危重症医学科,上海 200030上海交通大学医学院附属胸科医院呼吸与危重症医学科,上海 200030

医药卫生

非小细胞肺癌气道播散肺叶切除术辅助化疗

Non-small cell lung cancerSpread through air spacesSublobar resectionAdjuvant chemotherapy

《诊断学理论与实践》 2026 (4)

399-405,7

10.16150/j.1671-2870.2026.04.002

评论